BI
CCXI

BVF Inc’s ChemoCentryx, Inc. CCXI Stock Holding History

BVF Inc’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,414,515
Closed -$9.59M – 64
2019
Q3 		$9.59M Hold
1,414,515
– – 1.01% 29
2019
Q2 		$13.2M Sell
1,414,515
-50,000
-3% -$579K 1.44% 23
2019
Q1 		$20.3M Sell
1,464,515
-5,223,008
-78% -$59.7M 2.28% 17
2018
Q4 		$73M Sell
6,687,523
-86,237
-1% -$909K 9.54% 1
2018
Q3 		$85.6M Sell
6,773,760
-260,586
-4% -$3.14M 7.52% 2
2018
Q2 		$92.6M Sell
7,034,346
-166,970
-2% -$2M 9.04% 1
2018
Q1 		$97.9M Sell
7,201,316
-386,100
-5% -$3.98M 9.93% 1
2017
Q4 		$45.1M Hold
7,587,416
– – 5.44% 7
2017
Q3 		$56.3M Sell
7,587,416
-661,000
-8% -$5.49M 7.16% 3
2017
Q2 		$77.2M Buy
8,248,416
+257,844
+3% +$1.89M 11.99% 2
2017
Q1 		$58.2M Buy
7,990,572
+192,000
+2% +$1.38M 9.89% 2
2016
Q4 		$57.7M Sell
7,798,572
-265,447
-3% -$1.91M 11.59% 3
2016
Q3 		$48.7M Sell
8,064,019
-118,033
-1% -$558K 9.18% 2
2016
Q2 		$36.7M Hold
8,182,052
– – 7.83% 3
2016
Q1 		$20.4M Buy
8,182,052
+1,504,330
+23% +$5.48M 5.04% 9
2015
Q4 		$54.1M Sell
6,677,722
-895,771
-12% -$6.34M 9.22% 2
2015
Q3 		$45.8M Buy
7,573,493
+303,480
+4% +$2.19M 9.26% 2
2015
Q2 		$59.8M Sell
7,270,013
-1,033,071
-12% -$8.21M 10.56% 2
2015
Q1 		$62.7M Sell
8,303,084
-293,688
-3% -$2.29M 13.11% 2
2014
Q4 		$58.7M Hold
8,596,772
– – 11.42% 2
2014
Q3 		$38.7M Buy
8,596,772
+414,956
+5% +$2.19M 8.03% 5
2014
Q2 		$47.9M Buy
8,181,816
+385,300
+5% +$2.16M 7.57% 4
2014
Q1 		$51.7M Hold
7,796,516
– – 8.01% 3
2013
Q4 		$45.1M Buy
7,796,516
+2,418,900
+45% +$12.5M 7.9% 4
2013
Q3 		$29.9M Buy
5,377,616
+350,850
+7% +$3.79M 5.14% 7
2013
Q2 		$71.1M Buy
+5,026,766
New +$65.1M 13.79% 2

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc's CCXI Position: Q4 2019 in Review

BVF Inc sold out of ChemoCentryx, Inc. (CCXI) in Q4 2019, closing a stake of 1,414,515 shares — an estimated $9.59M sold.

BVF Inc first reported a position in CCXI in Q2 2013 and held it in 26 quarters. The position peaked at $97.9M in Q1 2018. 126 funds tracked by Wall St. Rank hold CCXI as of Q4 2019.

  • BVF Inc reported no remaining ChemoCentryx, Inc. position as of Q4 2019 after selling out during the quarter.
  • BVF Inc sold 1,414,515 ChemoCentryx, Inc. shares in Q4 2019, an estimated $9.59M.
  • BVF Inc first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 26 quarters.
  • BVF Inc's ChemoCentryx, Inc. position peaked at $97.9M in Q1 2018.
  • 126 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2019.

Based on BVF Inc's 13F filing for Q4 2019, filed 14 Feb 2020.